Obesity Clinical Trial
Official title:
Effects of Time Restricted Feeding on Body Weight and Metabolic Syndrome Severity in the Obese Adults
NCT number | NCT04243746 |
Other study ID # | TRF168 001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 3, 2020 |
Est. completion date | March 30, 2022 |
Verified date | May 2022 |
Source | RCSI & UCD Malaysia Campus |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The obesity rate in Malaysia is higher than the average world obesity rate. Central obesity is a component of metabolic syndrome (MetS) which is also made up of dyslipidemia, impaired glucose tolerance, and hypertension. MetS is a continuum in the risk of developing cardiometabolic complication. Time Restricted Feeding (TRF) involves an extended physiological overnight fast. Researchers believe that the timing of meal intake that matches with the circadian rhythms is as important as the calories intake to prevent obesity and its complications. The investigators hypothesize that TRF is effective in weight control and improvement of metabolic severity. Subjects will be randomized into either the control group, which practices QQH dietary plan or intervention group, which practices TRF as an adjunct to QQH dietary plan. Subjects will be followed up at week 12 and week 24 to assess adherence, efficacy and safety of TRF. This study intends to fill a few research gaps as follows: 1. Longer study duration of 6 months. 2. This is the first study amongst the Asian population. 3. Adherence level to TRF in real life setting is measured. This information can potentially predict the intensity level of TRF that are feasible for practice in real life and also its association with the efficacy of TRF. 4. TRF is defined as eating within a≤12-hour period and fasting for at least 12 hours per day. This is the shortest fasting window studied so far.
Status | Completed |
Enrollment | 74 |
Est. completion date | March 30, 2022 |
Est. primary completion date | March 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 59 Years |
Eligibility | Inclusion Criteria: 1. 20-59 years of age 2. BMI 27.5kg/m2 - 39.9kg/m2 3. Smart phone users 4. Willing to lose weight 5. Capable of giving informed consent, which includes compliance with the requirements and restrictions listed in the consent form and in the protocol. Exclusion Criteria: 1. Those with history of cardiovascular disease, cerebrovascular accidents, degenerative or inflammatory diseases of the nervous system; epilepsy, malignancy, gastrointestinal disorders, thyroid disorders, diabetes or medications which could have had metabolic effects. 2. Women who are pregnant or breastfeeding. 3. Those who are currently practicing any form of intermittent fasting or newly enrolled into a dietary or slimming program within the past 3 months. 4. Subjects with any medical condition, which in the investigator's judgment may be associated with increased risk to the subject or may interfere with study assessments or outcomes. 5. Those currently on medication for chronic illness. 6. Permanent night shift worker 7. Those who need to practise Ramadan fasting during the period of this study. |
Country | Name | City | State |
---|---|---|---|
Malaysia | Penang General Hospital | George Town | Penang |
Lead Sponsor | Collaborator |
---|---|
RCSI & UCD Malaysia Campus |
Malaysia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body weight (kg) | Mean body weight change will be calculated. | baseline - 24 weeks | |
Primary | Systolic BP (mmHg) | This is a parameter for the calculation of metabolic syndrome severity score. | baseline - 24 weeks | |
Primary | Fasting blood sugar (mmol/L) | This is a parameter for the calculation of metabolic syndrome severity score. | baseline - 24 weeks | |
Primary | Waist circumference (cm) | This is a parameter for the calculation of metabolic syndrome severity score. | baseline - 24 weeks | |
Primary | Serum triglyceride(mmol/L) | This is a parameter for the calculation metabolic syndrome severity score. | baseline - 24 weeks | |
Primary | Serum high density lipoprotein (HDL) (mmol/L) | This is a parameter for the calculation metabolic syndrome severity score. | baseline - 24 weeks | |
Secondary | Number of fasting hours per day | For assessment of adherence | baseline - 24 weeks | |
Secondary | Number of days achieving TRF | For assessment of adherence | baseline-24 weeks | |
Secondary | Incidence of treatment-emergent adverse events [Safety ] | baseline-24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |